Cannabis Law Report
OCTOBER 2, 2021
The results of our successful pivotal Phase 3 clinical trial were recently published in Nature Medicine and profiled on the front page of The New York Times. The right candidate will have a passion for clinical research in novel therapeutics and a proven track record of regulatory affairs experience. Key Responsibilities.
Cannabis Law Report
AUGUST 23, 2021
Details of a presentation to investors via the InvestorMeet Platform will be announced shortly. At the end of the programme, Evotec will provide the Company with a submission-ready regulatory document which will be used for submissions to regulatory agencies, as well as drug-batch approved and ready for First Time in Human clinical trials.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
NOVEMBER 19, 2021
It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. Competitive benefit package includes : Paid Time Off (PTO). European Regulatory Lead Executive Summary. Key Responsibilities.
NORML
SEPTEMBER 20, 2019
Essentially, the federal government has monopolized cannabis research, and ElSohly’s product, according to some scientists who’ve seen it, is unsuitable for clinical trials. Can you explain how it’s prepared for shipping at the University of Mississippi and how it comes packaged?
The Cannigma
OCTOBER 19, 2021
A clinical trial published in 2015 found that the test subjects had “significantly higher blood THC” levels when they used cannabis along with alcohol, and combining the two led to increased performance impairment. What to consider when mixing cannabis and alcohol.
Cannabis Law Report
JANUARY 9, 2019
Armed with their mission, in June 2018, Phoenix merged many of its partnership organisations together under the name Phoenix Life Sciences International Limited, placing expert botanists, biologists, industrial and organic chemists, medical doctors, researchers, packagers and distributors together under one roof.
Cannabis Law Report
MARCH 29, 2020
o Technology powered research: Virtual clinical trials and other accelerated technologies that mix the potential of new technologies with cannabis to create research insights quickly and more accurately, are being classified as Cannabis 3.0, triggering new innovations and improved data quality through better user experiences.
Expert insights. Personalized for you.
52 
Let's personalize your content